OBJECTIVES: To evaluate physicians' knowledge of therapy compliance, their attitudes towards it and their training needs in this field. DESIGN: Transversal, descriptive study using a questionnaire. SETTING: Primary care centres in Spain. PARTICIPANTS: Three thousand and thirty-four general practitioners. MAIN MEASUREMENTS: Definition of non-compliance, non-compliance in their own consultations and in the rest of Spain, methods of measurement, causes, association with therapy failure, efficacy and use of compliance-enhancing strategies, and need for training. RESULTS: Most participants (92%; 95% CI, 91.1-92.9) defined non-compliance as patients' failure to take 5%-20% of their pills. A total of 32.4% (95% CI, 30.9%-33.9%) of the physicians estimated that less than 10% of their patients were non-compliers, whereas 6.8% (95% CI, 6.0-7.6) thought this was also the rate in the rest of Spain. The preferred methods of measurement were patient response (77.0%; 75.7-78.4) and their own clinical experience (76.0%; 74.6-77.4). About half (50.7%) believed that lack of compliance was associated with therapy failure in more than 50% of cases. The presence of adverse side-effects was considered a very important cause of poor compliance by 81.9%. The most common and effective strategies were: use of single-dose drugs (84.3%; 83.1-85.5) and nursing support (84.9%; 83.8-86.0). Moreover, 65.2% (63.7-66.7) of the surveyed physicians had not received any education about compliance as medical students and 42% (40.4-43.6) said further training in compliance was needed. CONCLUSIONS: A high percentage of physicians define compliance incorrectly and believe that other doctors have more non-complying patients than they do. They tend to favour non-validated measuring methods and they lack training.
OBJECTIVES: To evaluate physicians' knowledge of therapy compliance, their attitudes towards it and their training needs in this field. DESIGN: Transversal, descriptive study using a questionnaire. SETTING: Primary care centres in Spain. PARTICIPANTS: Three thousand and thirty-four general practitioners. MAIN MEASUREMENTS: Definition of non-compliance, non-compliance in their own consultations and in the rest of Spain, methods of measurement, causes, association with therapy failure, efficacy and use of compliance-enhancing strategies, and need for training. RESULTS: Most participants (92%; 95% CI, 91.1-92.9) defined non-compliance as patients' failure to take 5%-20% of their pills. A total of 32.4% (95% CI, 30.9%-33.9%) of the physicians estimated that less than 10% of their patients were non-compliers, whereas 6.8% (95% CI, 6.0-7.6) thought this was also the rate in the rest of Spain. The preferred methods of measurement were patient response (77.0%; 75.7-78.4) and their own clinical experience (76.0%; 74.6-77.4). About half (50.7%) believed that lack of compliance was associated with therapy failure in more than 50% of cases. The presence of adverse side-effects was considered a very important cause of poor compliance by 81.9%. The most common and effective strategies were: use of single-dose drugs (84.3%; 83.1-85.5) and nursing support (84.9%; 83.8-86.0). Moreover, 65.2% (63.7-66.7) of the surveyed physicians had not received any education about compliance as medical students and 42% (40.4-43.6) said further training in compliance was needed. CONCLUSIONS: A high percentage of physicians define compliance incorrectly and believe that other doctors have more non-complying patients than they do. They tend to favour non-validated measuring methods and they lack training.
Authors: Juan Cárdenas-Valladolid; Carmen Martín-Madrazo; Miguel A Salinero-Fort; Enrique Carrillo de-Santa Pau; Juan C Abánades-Herranz; Carmen de Burgos-Lunar Journal: Drugs Aging Date: 2010-08-01 Impact factor: 3.923
Authors: José Miguel Baena-Díez; Claudia Gómez-Fernández; Mónica Vilató-García; Ernesto Javier Vásquez-Lazo; Alice Olivia Byram; Marc Vidal-Solsona Journal: Aten Primaria Date: 2011-02-20 Impact factor: 1.137
Authors: Narjis Fikri-Benbrahim; Victoria García-Cárdenas; Loreto Sáez-Benito; Miguel A Gastelurrutia; María P Faus; Marie P Schneider; Parisa Aslani Journal: Pharm Pract (Granada) Date: 2009-03-15